NICE guidance on nivolumab with ipilimumab for untreated advanced renal cell carcinoma

Autor:	Amanda I Adler, Adam Brooke, Linda J Landells, Ahmed Elsada
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty business.industry MEDLINE Ipilimumab medicine.disease Nice guidance Renal cell carcinoma Internal medicine medicine Carcinoma Neoplasm staging Nivolumab business medicine.drug
Zdroj:	The Lancet Oncology. 20:904-905
ISSN:	1470-2045
DOI:	10.1016/s1470-2045(19)30351-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c7e35687265fc1f7dd38709ae52e911b https://doi.org/10.1016/s1470-2045(19)30351-1 Zobrazit plný text záznamu